上海开开实业股份有限公司 关于使用暂时闲置募集资金进行现金管理的进展 并注销募集资金理财产品专用结算账户的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 | 股票代码：600272 | 股票简称：开开实业 | | | 编号：2025—076 | | --- | --- | --- | --- | --- | | 900943 | | 开开 | B 股 | | 募集资金专户。具体情况如下： 单位：万元 | 序 | 受托方名称 | 产品类型 | 实际投入金额 | 实际支取 | 现金管理 | 尚未支取 | | --- | --- | --- | --- | --- | --- | --- | | 号 1 | | | | 本金 3,500.00 | 收益 1.74 | 本金 12,049.00 | | 2 | | | | 3,300.00 | 3.97 | 8,749.00 | | 3 | 上海银行股份有限 公司南西支行 | 通 知 存 款 | 15,549.00 | 3,100.00 | 5.86 | 5,649.00 | ...

Core Insights - The primary focus of the news is the performance of the initial public offering (IPO) economy sector, which experienced a decline of 1.99% compared to the previous trading day, with notable losses from KaiKai Industrial [1] Group 1: Market Performance - On December 5, the Shanghai Composite Index closed at 3902.81, up by 0.7%, while the Shenzhen Component Index closed at 13147.68, up by 1.08% [1] - The IPO economy sector saw significant individual stock movements, with Shanghai Phoenix leading the gains at 4.40%, closing at 14.46 [1] Group 2: Stock Performance - KaiKai Industrial was the biggest loser, down by 5.70%, closing at 16.86, with a trading volume of 321,300 shares and a transaction value of 541 million [2] - Other notable decliners included WeiRu JuMi, down by 2.55%, and DiSu Fashion, down by 1.21% [2] Group 3: Capital Flow - The IPO economy sector experienced a net inflow of 133 million in main funds, while retail investors saw a net outflow of 100 million [2] - The table of capital flow indicates that "ZhiDeMai" had a net outflow of 45.07 million from main funds, while "JuRan ZhiJia" saw a net inflow of 42.82 million [3]

Market Overview - As of December 5, the Shanghai Composite Index closed at 3902.81 points, up 27.01 points, with a gain of 0.70% [1] - The Shenzhen Component Index closed at 13147.68 points, up 140.96 points, with a gain of 1.08% [1] - The ChiNext Index closed at 3109.30 points, up 41.81 points, with a gain of 1.36% [1] Stock Performance - A total of 82 A-shares had a turnover rate exceeding 20% on this day, with N-Moore-U reaching a turnover rate of over 50% [1] - N-Moore-U (688795) had a closing price of 600.50 CNY, with a turnover rate of 85.49% and a remarkable increase of 425.46% [1] - Other notable stocks with high turnover rates include: - Chuling Information (300250) with a turnover rate of 46.01% and a decline of 7.22% [1] - Sichuan Jinding (600678) with a turnover rate of 44.89% and a slight decline of 0.74% [1] - C China Uranium (001280) with a turnover rate of 44.11% and a decrease of 5.18% [1] - Jinfu Technology (003018) with a turnover rate of 43.71% and a marginal increase of 0.10% [1] Additional Notable Stocks - Weston (301315) closed at 66.30 CNY with a turnover rate of 43.08% and an increase of 5.20% [1] - Haixin Food (002702) closed at 9.55 CNY with a turnover rate of 42.20% and a gain of 10.02% [1] - Tongyu Communication (002792) closed at 29.47 CNY with a turnover rate of 41.60% and an increase of 4.73% [1] - Other stocks with significant turnover rates include: - Huawu Co., Ltd. (300095) with a turnover rate of 39.34% and a decline of 2.40% [1] - Zhongneng Electric (300062) with a turnover rate of 38.89% and an increase of 12.76% [1] - Xiaocheng Technology (300139) with a turnover rate of 38.76% and a gain of 14.62% [1]

开开实业(600272)今日上涨8.17%，全天换手率27.67%，成交额7.53亿元，振幅14.92%。龙虎榜数据显 示，营业部席位合计净买入4998.77万元。 上交所公开信息显示，当日该股因日换手率达27.67%上榜，营业部席位合计净买入4998.77万元。 证券时报·数据宝统计显示，上榜的前五大买卖营业部合计成交1.44亿元，其中，买入成交额为9719.27 万元，卖出成交额为4720.49万元，合计净买入4998.77万元。 具体来看，今日上榜营业部中，第一大买入营业部为广发证券股份有限公司阳江体育路证券营业部，买 入金额为2626.53万元，第一大卖出营业部为国泰海通证券股份有限公司总部，卖出金额为1110.18万 元。 资金流向方面，今日该股主力资金净流入9263.79万元，其中，特大单净流入8070.88万元，大单资金净 流入1192.91万元。近5日主力资金净流入2.00亿元。 10月31日公司发布的三季报数据显示，前三季度公司共实现营业收入8.25亿元，同比增长10.76%，实现 净利润1286.78万元，同比下降62.81%。（数据宝） 开开实业12月4日交易公开信息 | 买/ | 会员 ...

Group 1 - The stock of Kaikai Industrial (600272) experienced a decline of 1.20% with a turnover rate of 28.53% and a trading volume of 788 million yuan, showing a fluctuation of 13.72% throughout the day [1][2] - The stock was listed on the exchange due to its high turnover rate, with a net selling amount of 24.37 million yuan from brokerage seats [2] - The top five brokerage seats accounted for a total transaction of 123 million yuan, with a buying amount of 49.42 million yuan and a selling amount of 73.79 million yuan, resulting in a net selling of 24.37 million yuan [2] Group 2 - The main buying brokerage was Guotai Junan Securities with a purchase amount of 11.19 million yuan, while the largest selling brokerage was Kaiyuan Securities with a selling amount of 26.90 million yuan [2] - The stock saw a net outflow of 11.01 million yuan in principal funds, with significant outflows of 5.65 million yuan from large orders and 5.36 million yuan from major orders, although there was a net inflow of 99.29 million yuan over the past five days [2] - For the third quarter, the company reported a total revenue of 825 million yuan, representing a year-on-year growth of 10.76%, while net profit was 12.87 million yuan, reflecting a year-on-year decline of 62.81% [2]

Group 1: Market Performance - The A-share market experienced rapid rotation of hot themes, with the Shanghai Composite Index down 0.42%, the Shenzhen Component Index down 0.68%, and the ChiNext Index down 0.69% at the close [1] - The total market turnover reached 1,607.3 billion [1] Group 2: Sector Performance - The pharmaceutical commercial sector showed strong performance, ranking first in the increase of sector shares, with Haiwang Biological achieving a "five consecutive limit-up" and over 290,000 sealed orders remaining at the limit-up price [1] - The Fujian sector also performed well, with stocks like Jiarong Technology and Haixin Food hitting limit-up prices [1] - Energy metals and film industry sectors, which performed well previously, experienced adjustments [1] Group 3: Market Outlook - The market is expected to remain in a phase of frequent style switching in December, primarily characterized by structural trends [1] - Key areas for potential deployment include technological innovation, domestic demand expansion, anti-involution, and stabilizing the real estate sector, with industry meetings likely to catalyze thematic trends [1] - External uncertainties, particularly the potential impact of the upcoming Federal Reserve meeting on global market liquidity, are also highlighted [1] Group 4: Health Sector Insights - The China CDC reported that the flu positivity rate among emergency and outpatient cases is close to 45%, indicating a rapid increase in flu cases, with some provinces reaching high epidemic levels [2] - According to Everbright Securities, the demand for cold medicines in Q4 is expected to exceed market expectations due to the rising trend of flu cases [2] - The introduction of multi-pathogen detection products and convenient diagnostic tools is anticipated to support the performance of related pharmaceutical companies [2]

Core Viewpoint - The "street vendor economy" sector experienced a decline of 0.45% on December 2, with Penghui Energy leading the drop. The Shanghai Composite Index closed at 3897.71, down 0.42%, while the Shenzhen Component Index closed at 13056.7, down 0.68% [1]. Group 1: Market Performance - The street vendor economy sector saw a net outflow of 214 million yuan from main funds, while retail investors contributed a net inflow of 132 million yuan [2][3]. - Key stocks in the street vendor economy sector showed varied performance, with Hai Xin Food leading with a 10.05% increase, while Penghui Energy fell by 5.00% [1][2]. Group 2: Individual Stock Analysis - Hai Xin Food (002702) closed at 8.76 yuan, with a trading volume of 1.47 million shares and a transaction value of 12.39 million yuan [1]. - Penghui Energy (300438) closed at 54.96 yuan, with a trading volume of 332,200 shares and a transaction value of 1.848 billion yuan [2]. - Other notable performers included Maoye Commercial (600828) with a 9.93% increase and a transaction value of 842 million yuan, and Xiaosong Co. (002723) with a 6.04% increase and a transaction value of 300 million yuan [1][2].

Group 1 - The pharmaceutical commercial sector increased by 1.63% compared to the previous trading day, with Renmin Tongtai leading the gains [1] - The Shanghai Composite Index closed at 3897.71, down 0.42%, while the Shenzhen Component Index closed at 13056.7, down 0.68% [1] - Key stocks in the pharmaceutical commercial sector showed significant gains, with Renmin Tongtai rising by 10.03% to a closing price of 13.49 [1] Group 2 - The main capital inflow in the pharmaceutical commercial sector was 561 million yuan, while retail investors experienced a net outflow of 454 million yuan [2] - The stock Renmin Tongtai had a net inflow of 179 million yuan from main capital, representing 30.72% of its trading volume [3] - Other notable stocks included Haiwang Biological with a net inflow of 160 million yuan and Kaikai Industrial with a net inflow of 101 million yuan from main capital [3]

Group 1 - The core viewpoint of the news is that Shanghai Kaikai Industrial Co., Ltd. has seen a significant increase in its stock price, rising by 7.82% to reach 16.40 CNY per share, with a trading volume of 335 million CNY and a turnover rate of 13.52%, resulting in a total market capitalization of 4.307 billion CNY [1] - The company, established on August 4, 1997, and listed on February 28, 2001, primarily engages in traditional Chinese medicine distribution, Chinese medicine services (including consultation), and clothing wholesale and retail [1] - The revenue composition of the company's main business includes wholesale at 74.48%, retail at 18.18%, health services at 4.42%, leasing at 1.77%, and other services at 1.14% [1] Group 2 - Among the top ten circulating shareholders of Kaikai Industrial, a fund under Huatai-PineBridge Fund ranks as a significant shareholder [2] - The China Securities Shanghai State-Owned Enterprises ETF (510810) reduced its holdings by 164,200 shares in the third quarter, now holding 787,500 shares, which accounts for 0.33% of the circulating shares [2] - The ETF has achieved a year-to-date return of 7.11%, ranking 3709 out of 4206 in its category, and a one-year return of 9.16%, ranking 3326 out of 4012 [2]

Group 1 - The pharmaceutical commercial sector is experiencing a significant rally, with Haiwang Biological achieving five consecutive trading limits [1] - Renmin Tongtai has reached the daily limit, indicating strong market interest [1] - Other companies such as Yaoyigou, Hefeng China, Huaren Health, Yifeng Pharmacy, and Kaikai Industrial are also seeing upward movement in their stock prices [1]